Veterinary Medicines

Myodine 25 mg/ml solution for injection for dogs and cats

Authorised
  • Nandrolone laurate
Download as PDF

Product identification

Medicine name:
Myodine 25 mg/ml solution for injection for dogs and cats
Myodine vet, 25 mg/ml süstelahus koertele ja kassidele
Active substance:
  • Nandrolone laurate
Target species:
  • Dog
  • Cat
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Nandrolone laurate
    25.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Dog
    • Cat
  • Subcutaneous use
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA14AB01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Estonia
Package description:
  • Cardboard box with 1 clear type I glass vial containing 5 ml with a coated bromobutyl rubber stopper and aluminium cap.Pack size:Box with 1 vial of 5 ml
  • Cardboard box with 1 clear type II glass vial containing 10 ml with a coated bromobutyl rubber stopper and aluminium cap.Pack size:Box with 1 vial of 10 ml
  • Cardboard box with 1 clear type II glass vial containing 20 ml with a coated bromobutyl rubber stopper and aluminium cap.Pack size:Box with 1 vial of 20 ml
  • Cardboard box with 6 clear type I glass vials containing 5 ml with a coated bromobutyl rubber stopper and aluminium cap.Pack size:Multi-pack with 6 vials of 5 ml
  • Cardboard box with 6 clear type II glass vials containing 10 ml with a coated bromobutyl rubber stopper and aluminium cap.Pack size:Multi-pack with 6 vials of 10 ml
  • Cardboard box with 6 clear type II glass vials containing 20 ml with a coated bromobutyl rubber stopper and aluminium cap.Pack size:Multi-pack with 6 vials of 20 ml
  • Cardboard box with 10 clear type I glass vials containing 5 ml with a coated bromobutyl rubber stopper and aluminium cap.Pack size:Multi-pack with 10 vials of 5 ml
  • Cardboard box with 10 clear type II glass vials containing 10 ml with a coated bromobutyl rubber stopper and aluminium cap.Pack size:Multi-pack with 10 vials of 10 ml
  • Cardboard box with 10 clear type II glass vials containing 20 ml with a coated bromobutyl rubber stopper and aluminium cap.Pack size:Multi-pack with 10 vials of 20 ml

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Le Vet. Beheer B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Produlab Pharma B.V.
Responsible authority:
  • State Agency Of Medicines
Authorisation number:
  • 2033
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0358/001
Concerned member states:
  • Austria
  • Belgium
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Greece
  • Hungary
  • Iceland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 3/05/2024
Download
Estonian (PDF)
Published on: 12/04/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."